Yueying Weng – Trademark Portfolio

Entity Type: 01

Yueying Weng holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 26 (Fancy Goods) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FORNDER, FEARATHE, and KIANSEUS. The owner is based in Fuqing,Fujian.

No.61 Qiantang,Hecuo Village

Fuqing,Fujian 350309 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KIANSEUS
KIANSEUS
Registered 2020
FEARATHE
FEARATHE
Registered 2020
FORNDER
FORNDER
Registered 2020

Trademark Classifications

Yueying Weng's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

26
Fancy Goods (2 filings)

Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Yueying Weng have?

Yueying Weng has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Yueying Weng file in?

Yueying Weng files trademarks across 2 Nice Classification classes. The most active classes are Class 26 (Fancy Goods), Class 5 (Pharmaceuticals). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.

What are Yueying Weng's most well-known trademarks?

Yueying Weng's registered trademark portfolio includes well-known marks such as FORNDER, FEARATHE, and KIANSEUS. These are among 3 currently registered trademarks in the portfolio.

What is Yueying Weng's trademark registration success rate?

Yueying Weng has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.